Description
Highly purified and extremely active Vaccinia Capping Enzyme (VCE)
For extremely efficient enzymatic formation of Cap0-capped mRNA from in vitro transcribed mRNA
Cap1 mRNA can be obtained by using VCE in combination with 2′-O-Methyltransferase (2OM)
- High purity-grade recombinant enzyme for mRNA manufacturing workflows involving post-transcriptional mRNA capping
- Integrates 3 enzymatic activities required for capping: RNA triphosphatase, guanylyltransferase, and guanine-N7-methyltransferase (requiring GTP, and SAM as a methyl donor)
- Efficiently adds an m⁷G cap to the 5′ end of IVT-generated mRNA producing Cap0-capped mRNA with up to 100% capping efficiency in a single reaction
The 5′ cap structure (m⁷GpppN) (Cap0), also known as the methylguanosine cap of mRNA is essential for translation initiation, protection from RNase degradation, and enhancement of mRNA stability during splicing and nuclear export. Biori´s Vaccinia Capping Enzyme is a multi-step purified recombinant highly efficient enzyme preparation manufactured by Biori Biotech to GMP standards. The enzyme preparation integrates the three enzymatic activities required for capping: RNA triphosphatase, guanylyltransferase, and guanine-N7-methyltransferase. In the presence of S-adenosylmethionine (SAM) as a methyl donor as well as guanosine triphosphate (GTP), VCE directly and efficiently adds an m⁷G cap to the 5′ end of in vitro transcribed mRNA in the correct orientation, producing Cap0-capped RNA with up to 100% capping efficiency in a single reaction.
Contents:
1000 ul Vaccinia Capping Enzyme (10 U/ul), 10000 Units, sufficient for 1000 Capping Reactions (based on the input of 10 U for 50 pmol denatured mRNA)
2000 ul 10x Capping Buffer
1000 ul 10mM GTP Solution
200 ul 32mM SAM (S-adenosylmethionine)
NOTE: Combining VCE with 2′-O-Methyltransferase (2OM) enables the formation of Cap1-capped mRNA from in vitro transcribed mRNA.
Cap1 (m7GpppNm), common in higher eukaryotes such as mammals, includes an additional methyl group at the 2′-O position of the first nucleotide, and has been shown to be important for evading the intracellular immune system, and to increase the stability and translational activity of the mRNA.
